Health Care/Hospital
Sourcing Ideal Medical Device Materials: Experience ICP DAS - BMP medical-grade TPUs at 2023 CMEF Shanghai, China
HSINCHU, May 3, 2023 /PRNewswire/ -- Material "safety" and "quality" are paramount to medical device manufacturers. Therefore, ICP DAS - BMP (Biomedical Polymers), aTaiwan medical-grade TPU (thermoplastic polyurethane) supplier, will partake in CMEF (ICMD) to further make known our highly-stable ...
2023-05-03 09:46
2783
Completion of Enrollment in Cohorts C and G of China Phase II Clinical Study of Osemitamab (TST001) in Combination with CAPOX with or without Nivolumab as First-line Treatment of Gastric/Gastro-esophageal Junction Cancer Patients
SUZHOU, China, May 3, 2023 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta") (HKEX: 06628), a clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, research, development and manufacturing of antibody-based therapeutics,announces that the enrollment of ...
2023-05-03 08:00
3572
ZEISS Presents New Surgical Workflow Innovations at ASCRS
New products help doctors diagnose and treat patients within the cataract and corneal refractive workflows. JENA, Germany and DUBLIN, Calif., May 3, 2023 /PRNewswire/ -- ZEISS Medical Technology will showcase new surgical workflow innovations at the American Society of Cataract and Refractive Su...
2023-05-03 02:09
2400
Turacoz Forges Ahead with Veeva Content Certification & Training for Professionals
UTRECHT, Netherlands and NEW DELHI, May 3, 2023 /PRNewswire/ -- Turacoz Healthcare Solutions has been making strides in the field of medical communications using cutting-edge technologies. The demand for high-quality scientific and medical writing is increasing, and Turacoz is leading the way in ...
2023-05-03 01:55
2417
Topline Results from Two-Year Primary Efficacy Endpoint in Pivotal Phase 3 DUPLEX Study of Sparsentan in Focal Segmental Glomerulosclerosis
The DUPLEX Study did not achieve the primary efficacy eGFR slope endpoint over 108 weeks of treatment Secondary and topline exploratory endpoints trended favorably for sparsentan Treatment with sparsentan resulted in a reduction of proteinuria that was sustained through 108 weeks of treatment S...
2023-05-03 00:22
3147
iHerb Names Miriee Chang as Chief Operating Officer
Newly established role will further streamline operations and enhance operational effectiveness IRVINE, Calif., May 3, 2023 /PRNewswire/ -- iHerb Holdings, LLC, announced that Miriee Chang has been named its Chief Operating Officer (COO). Mrs. Chang brings significant leadership experience to th...
2023-05-03 00:14
2579
Cellenkos Announces First Patient Dosed with CK0803 Cell Therapy for Treatment of Amyotrophic Lateral Sclerosis
* First patient dosed with CK0803 Treg cells for treatment of amyotrophic lateral sclerosis (ALS). * Ongoing Phase 1/1b study evaluating safety and efficacy of CK0803. HOUSTON, May 3, 2023 /PRNewswire/ -- Cellenkos® Inc., a clinical stage biotechnology company focused on developing allogeneic...
2023-05-03 00:07
1903
AvantGuard Applauded by Frost & Sullivan for Extending the Life of Chlorine-based Disinfectants for Sustained Efficacy with Its Residual Antimicrobial Solutions
The residual antimicrobial solutions provide continuous efficacy, minimize the frequent antimicrobial dosage on surfaces, and reduce operational costs and time in the healthcare and food and beverage industries. SAN ANTONIO, May 2, 2023 /PRNewswire/ -- Frost & Sullivan recently assessed the Nort...
2023-05-02 20:00
1827
Ascletis Announces ASC40, a First-in-Class, Once-Daily Oral FASN Inhibitor, Achieved Endpoints in Phase II Clinical Trial for Acne
HANGZHOU and SHAOXING, China, May 2, 2023 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") announces today that ASC40 (Denifanstat), a first-in-class, once-daily oral fatty acid synthase (FASN) inhibitor, achieved primary and key secondary endpoints in Phase II clinical trial for acn...
2023-05-02 17:30
2816
Grand and People's Choice Stevie® Award Winners Announced in 2023 Asia-Pacific Stevie Awards
Cisco Systems Named Organization of the Year; More Than 9,300 Were Cast in the Public Vote FAIRFAX, Va., May 2, 2023 /PRNewswire/ -- The Stevie® Awards, organizer of the world's premier business awards programs, announced the winners of five Grand Stevie Award trophies, plus nine winners of a Pe...
2023-05-02 15:37
2378
Cytiva and Pall Life Sciences complete integration to create a global innovation and solutions leader in biotechnology
* Combined broad and differentiated portfolio with trusted technologies and commercial and service organizations * Customers will have simpler and greater access to industry-leading expertise, tools, and services AMERSHAM, United Kingdom, May 2, 2023 /PRNewswire/ -- Cytiva and the life scienc...
2023-05-02 12:01
3159
First Patients in Canada Imaged with Illuccix®: Now Commercially Available Nationwide
MELBOURNE, Australia, May 2, 2023 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces first patients have been imaged inCanada with its commercially available prostate cancer imaging agent, Illuccix® [kit for the preparation of gallium (68Ga) PSMA-11 for i...
2023-05-02 05:00
2118
The Clinician to participate at Digital Health Festival 2023 in Melbourne
MELBOURNE, Australia, May 1, 2023 /PRNewswire/ -- The Clinician
2023-05-01 20:00
2385
Concept Medical received IDE approval to investigate safety and efficacy of its MagicTouch Sirolimus Coated Balloon Catheter for the treatment of small coronary artery disease
TAMPA, Fla., May 1, 2023 /PRNewswire/ -- The US FDA has granted an
Investigational Device Exemption (IDE) approval for Concept Medical Inc's novel
MagicTouch
2023-05-01 18:30
2560
Zimmer Biomet Announces Acquisition of OSSIS
SINGAPORE, May 1, 2023 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced it has reached a definitive agreement to acquire OSSIS, a privately-held medical device company that specializes in personalized 3D printed implants, as wel...
2023-05-01 12:00
4696
GILEAD SCIENCES ANNOUNCES LAUNCH OF ASIA PACIFIC RAINBOW GRANT 2023
–Gilead Sciences Celebrates the Fifth Anniversary Milestone of the Asia Pacific Rainbow Grant, with More Than US$4.5 Million Awarded to Organizations across the Asia Pacific Region to Date – – Grant Program in 2023 Invites HIV-Focused Community-Based Organizations to Apply for Funding for Innova...
2023-05-01 11:00
2987
ZIRCON Phase III Kidney Cancer Imaging Study Presented at AUA: New Data Confirms Efficacy in Masses 2cm or Smaller
MELBOURNE, Australia, May 1, 2023 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces additional positive results from its completed pivotal Phase III ZIRCON study of TLX250-CDx (89 Zr-DFO-girentuximab) in clear cell renal cell carcinoma (ccRCC) (ClinicalT...
2023-05-01 08:58
2492
Engineering Biology Innovation Forum IV, Guangming Science City 2023SynBio China II and Asian Synthetic Biology Innovation Forum I Held in Shenzhen
SHENZHEN, China, April 28, 2023 /PRNewswire/ -- Engineering Biology Innovation Forum IV, Guangming Science City 2023SynBio China II and Asian Synthetic Biology Innovation Forum I were held inShenzhen on April 27th – 28th. The event assembled distinguished guests from political, industry, univers...
2023-04-28 20:36
3210
Cathay Life Celebrates Fifth Celent Model Insurer Award
Research and development of new risk control model attracts international attention TAIPEI, April 28, 2023 /PRNewswire/ -- Cathay Life Insurance has once again been recognized for its expertise, taking home the company's fifth Model Insurer Award from Celent, the global consulting and research c...
2023-04-28 19:45
5206
Paying it forward: SM marks another year of positive community impact
PASAY CITY, Philippines, April 28, 2023 /PRNewswire/ -- Glenn Paul Añover
Embodo is among the 'Yolanda' scholars helped by SM Foundation, Inc. of the SM
Group, following the devastation of the super typhoon in the country in 2013.
2023-04-28 16:12
3171
Week's Top Stories
Most Reposted
Troy Animal Healthcare Strengthens Quality Operations with Veeva Vault Quality
[Picked up by 321 media titles]
2024-05-17 07:00Ultima Markets Recognised as Most Popular Broker 2024 by BrokersView
[Picked up by 319 media titles]
2024-05-15 12:00
Home to half of the world's top 10 trending tourism destinations, Asia Pacific is making a comeback: Mastercard Economics Institute on travel in 2024
[Picked up by 303 media titles]
2024-05-16 15:00
US-BASED PANDUIT ELEVATES MANUFACTURING LANDSCAPE WITH NEW STATE-OF-THE-ART PLANT IN JOHOR BAHRU, MALAYSIA
[Picked up by 274 media titles]
2024-05-16 09:39
Trip.com Group and Rezdy Join Forces to Offer New Travel Experiences Around the World
[Picked up by 229 media titles]
2024-05-14 18:07Most Read
Huawei Launching the All-Scenario Smart Telecom Power Solutions
2024-05-11 17:52
9970
Ultima Markets Recognised as Most Popular Broker 2024 by BrokersView
2024-05-15 12:00
6670
Traveloka strengthens sustainability pledge as world's first Platinum Sponsor of GSTC
2024-05-13 16:42
5807
Casio to Release G-SHOCK-Surfrider Foundation Collaboration
2024-05-15 09:00
4898
